logo
Let's talk about death and dying

Let's talk about death and dying

Mail & Guardian6 days ago
Medical school prepares our future doctors to save lives. But with death being the endpoint for all of us, shouldn't we be talking about it? Photo: Maria Luísa Queiroz/Unsplash
There is an old joke about someone collapsing on an aeroplane mid-flight. The flight attendant shouts out, 'Is there a doctor onboard?' A passenger comes forward but just stands there. 'Why aren't you doing anything? He's dying!' the flight attendant cries. 'I'm a doctor of philosophy,' the passenger says dryly. 'We're all dying.'
I can relate. I'm a moral philosopher, and a lot of my professional life has focused on matters relating to death. From the rightness or wrongness of abortion, to the morality of capital punishment or the ethics of using dead bodies for medical research, I've found that death, in the abstract, is an endlessly fascinating subject.
But death is no longer just abstract for me.
A few years ago, I lost my mother to cancer. I am currently facing a serious health probem of my own. So I've had a lot of time professionally and personally to contemplate death in the not-so-abstract.
I teach in the department of medicine at the University of Cape Town, where I talk to my students about respecting patients' choices, avoiding causing harm, helping others and treating all people fairly. Developed by biomedical ethicists Tom Beauchamp and James Childress in the 1970s, these
In my classes, we talk about patients' rights, including the right to refuse lifesaving treatment like blood transfusions on religious grounds, or the right to have life-sustaining treatments withdrawn, like saying no to more chemotherapy or other cancer treatments. But we don't talk about what happens after patients exercise these rights, and what it may feel like for the treating clinicians when their patients die from what seem like preventable deaths.
Difficult conversations
In June I attended the annual
In my workshop on using the tools of philosophy to resolve ethical dilemmas, I used an example of a child with terminal cancer to illustrate a point, and during the break, one of the workshop participants, a
I wanted to rage and cry at the injustice of the situation, but she seemed calm and at peace. These different reactions suggested to me that there is a critical need to transform the way we relate to death — and we can start by having conversations about it.
We can start with our medical students who are focused on their future jobs of 'saving lives'. Of course, I'm not suggesting we shouldn't train our healthcare practitioners to focus on saving lives. But I do think — given that we are all going to die — that we shouldn't avoid the subject as many of us do. We could do so much better to prepare our students ethically, emotionally and practically for one of the critical things they will have to deal with in their professions. If we talk about death with our students, and how it feels to see someone die, perhaps they will be better equipped to help support those who are dying and those who are grieving.
Talking about death is challenging. It touches all of us in different ways, whether in our personal experience or professionally. We may have competing views about it, informed by our experience, our religion, our culture. But 'difficult' is not a reason not to have the conversation.
Here's the thing: not only do we not talk enough about death with our students, but we also don't talk about dying. I recently read palliative paediatrician Alastair McAlpine's wonderful
'No lecture had prepared me for this. No one had counselled me on how to comfort someone who was dying. Or what to say to someone who was in such pain and distress. I had studied the pharmacological approach to pain management, but not how to deal with loneliness, fear and sadness. Nor how to manage my own feelings around a patient who was slipping away. I didn't know what to do or say. In the face of death, words felt impotent and inadequate.'
Patient mortality, professional failure
For many philosophers, the task is to analyse and understand death. For me, the task is also to make space for it: in our classrooms, our hospitals, and our hearts.
In our classrooms, we need to go beyond asking students what kind of doctors they want to be and ask them to think about what kind of doctors they want to be when their patients are dying.
We need to have conversations about how to transition from offering care that cures to care that comforts patients with irreversible conditions such as terminal cancer or end-stage organ failure. When we teach students to be empathetic to their patients' and families' situations, we also need to caution them about becoming overwhelmed and not taking on their patients' suffering as if it were their own. If we don't teach them how to manage their own mental health, we risk them suffering from depression, burnout or compassion fatigue. We need to teach them to learn from experience without being consumed by it.
In our clinics and hospitals, we need to challenge the idea that patient mortality equates to professional failure. We can reframe morbidity and mortality meetings, which allow clinicians to review patient care and treatment, as opportunities for learning rather than for shaming. We can encourage our colleagues to view each other — and themselves — as companions who support patients in the full human experience rather than as warriors fighting inevitable biological processes.
Chocolates and jokes
Upon receiving my recent diagnosis, my first thoughts and words were 'I don't want to die'. I realise now that what I meant was, I don't want to die now. Or soon.
But having to consider that I will die at some point has helped me think about how I'd like to live with whatever time I have left — and hopefully it's a lot. It's also helped me talk to others about how I'd like to die and what I'd like after my death. (For example, I don't want the word 'feisty' on my tombstone, however appropriate a description of me it might be.)
Talking about death has reduced the anxiety I had about death, and given me some assurance that when the time comes, I can trust others to know that I will have dignity in dying. That if I cannot care for myself, or speak about what I want, they will be able to do so for me, authentically — and hopefully with a dash of dark humour. I'm not religious, so I asked for chocolates and jokes rather than thoughts and prayers.
I believe that how we care for ourselves and for others is fundamental to who and what we are. How we live with the dying can say a great deal about who we are, and how we die can say a great deal about how we've lived.
Heidi Matisonn is a senior lecturer in bioethics in the EthicsLab at UCT's Neuroscience Institute and department of medicine.
This story was produced by the
. Sign up for the
.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Drowning rates in SA go up while global figures drop, says Lifesaving SA
Drowning rates in SA go up while global figures drop, says Lifesaving SA

The Herald

time2 days ago

  • The Herald

Drowning rates in SA go up while global figures drop, says Lifesaving SA

Drownings in South Africa are increasing, bucking the global trend where the rates are dropping, Lifesaving South Africa (LSA) warned in a statement to mark World Drowning Prevention Day on Friday. 'While global drowning deaths have dropped by 38% over the past two decades, South Africa's rates are rising,' the federation said, adding the World Health Organisation (WHO) estimated at least 2,700 drowning deaths a year, with children under five at the greatest risk. Africa has seen a 3% decline, while South Africa has struggled to deal with the threat. WHO statistics showed at least 1,600 drowning deaths a year in the country, but these figures did not include deaths from flooding disasters, LSA said. 'In South Africa the crisis is worsened by climate change and flooding disasters, such as those in the Eastern Cape in June, and preventable risks such as unsafe farm dams and canals, inadequate water and sanitation infrastructure and traditional baptism ceremonies at rivers and along coastline.'

Poultry sector recovering, prices not expected to increase
Poultry sector recovering, prices not expected to increase

Mail & Guardian

time3 days ago

  • Mail & Guardian

Poultry sector recovering, prices not expected to increase

South Africa's poultry sector is recovering from a devastating outbreak of bird flu and has capacity to meet local consumer demand. (Madelene Cronje) South Africa's The department of agriculture rolled out mass inoculations earlier this month to protect the industry from highly pathogenic In 2023, millions of birds had to be culled, hampering production and driving up poultry and egg prices. The inoculation campaign kicked off with the vaccination of 200 000 broiler breeders at poultry producer Astral. The birds represent 5% of the company's total breeding stock, the department said. Industry experts have welcomed the inoculation drive. 'We had two cases of HPAI in the country, but both were contained and did not spread with minimum losses in terms of production,' said Izaak Breitenbach, the chief executive of the South African Poultry Association. 'We still have an additional one million birds per week slaughter capacity. We currently slaughter about 21.5 million birds per week.' That number reflects normal production levels, which may rise slightly toward December because sales typically increase in the second half of the year. Breitenbach said the industry also has the capacity to exceed this demand if needed 'The industry can cover an increase in demand of about 10% with local production in the short term and probably more in the long term.' Agriculture economists said the success rate for the inoculations will depend on how well future outbreaks are contained. (Graphic: John McCann/M&G) 'There are great expectations that South Africa's recent efforts to vaccinate poultry against avian flu will lessen the likelihood of another devastating outbreak similar to the one that occurred in 2023. Particularly in light of the seasonal influenza outbreak, which usually starts in April and peaks in September each year,' said Thabile Nkunjana, of the National Agricultural Marketing Council. 'However, the initial vaccination is reportedly for at least 200 000 broilers, which is extremely small compared to the size of the industry as a whole. As a result, there is still a chance of an outbreak related to South African poultry production, as well as a current risk of disruptions in the poultry supply, which frequently results in prices that have a negative impact on consumers The layer side of the poultry industry, which raises chickens specifically for egg production, is still producing at lower levels comparable to those before the 2023 outbreak, Nkunjana noted. 'If an outbreak were to occur, the industry would likely experience the same level of pressure as it did in 2023, and egg prices would probably rise once more,' he said. Experts warned that the cost of bird feed could hamper poultry production. Prices have increased on the back of climate conditions as well as international supply. 'Initially feed costs rose when world prices increased sharply in the aftermath of the pandemic and associated supply chain challenges, challenging weather in some key production regions and Russia's invasion of Ukraine,' said Tracy Davids, the executive director for commodity markets and foresight at the Bureau for Food and Agricultural Policy. 'When world prices came down, South African prices stayed higher due to the summer drought of 2024. So, feed costs have increased much more than meat prices over the past five years, making life difficult for all livestock producers, but particularly poultry that use feed very intensively. It's the biggest cost component in the sector.' With feed prices declining and the partial lifting of the ban on Brazilian chicken imports earlier this month, the prospects for the sector are looking positive, Davids added. The ban was implemented after Brazil also reported disease outbreaks, but was lifted to support South African consumers' food security, alleviate cost pressures, and help stabilise the supply chain, said Nkunjana.

Aid cuts, including by UK, undermine progress on fight against superbugs
Aid cuts, including by UK, undermine progress on fight against superbugs

Mail & Guardian

time3 days ago

  • Mail & Guardian

Aid cuts, including by UK, undermine progress on fight against superbugs

Antimicrobial resistance silent pandemic that already claims more than 1.3 million lives every year. File photo A recent global economic model warns that antimicrobial resistance (AMR) may cost the world economy up to This escalating threat coincides with a decline in international support for AMR surveillance. The Low- and middle-income countries, including South Africa, are likely to bear the heaviest burden because of under-resourced health systems, limited surveillance capacity and growing barriers to effective treatments. AMR arises when microorganisms evolve mechanisms to withstand the effects of antibiotics intended to eliminate them. As resistance spreads, infections that were once easily treatable become increasingly difficult, and sometimes impossible, to cure. This silent pandemic is already responsible for more than By 2050, resistant infections could reduce global GDP by up to 3.1% and push millions into poverty as a result of the cost of prolonged illness and ineffective treatment. Health systems, especially in countries already facing a high burden of disease, are at risk of being overwhelmed. The But Experts caution that even partial reductions in funding may accelerate the spread of AMR in high-risk regions. Such cutbacks can delay the detection of resistant pathogens, disrupt surveillance efforts and weaken public health responses. The consequences are clear: more infections, higher mortality rates and mounting pressure on already overstretched health systems. AMR does not respect borders. Resistant bacteria can emerge in one location and spread globally through travel, trade and migration. Inadequate surveillance in one part of the world increases vulnerability everywhere. Many low- and medium-income countries face compounded problems: limited access to diagnostics, overuse or misuse of antibiotics in both clinical and agricultural settings, as well as underinvestment in water, sanitation and hygiene infrastructure. Surveillance programmes supported by international aid help fill these gaps by enabling early detection and informed response. Cutting funding now undermines global preparedness just as AMR risks are accelerating. While AMR is a long-term challenge, the window for effective action is narrowing. Delaying investment now will probably increase the cost and complexity of response in the future. According to recent economic analyses, every dollar spent on AMR containment today could save up to $20 in future health and productivity costs. Continued investment in surveillance, laboratory capacity, workforce training and antimicrobial stewardship is essential for all countries and for global health security. Multilateral partnerships, sustained funding, and equitable access to innovation are critical pillars of any effective AMR strategy. What can be done? Given the recent decline in global funding, it is essential to explore alternative strategies to sustain and strengthen AMR efforts. Reinforce multilateral funding: Donor countries should explore shared funding mechanisms to sustain critical AMR programmes beyond bilateral commitments. Strengthen regional cooperation: Regional AMR surveillance networks can improve resilience and facilitate data-sharing, even in the face of international funding cuts. Mobilise domestic resources: Prioritise public health investment in laboratory systems, data infrastructure, and training to reduce reliance on fluctuating aid flows. Promote responsible antimicrobial use: Stewardship programmes in human and veterinary medicine are essential to slow the development of resistance. Invest in research and equitable access: Support for the development and fair distribution of new antibiotics, vaccines, and diagnostics must remain a global priority. AMR is one of the most urgent and complex public health issues of our time. Progress made in the past decade, through global collaboration, investment and capacity-building now stands at risk. At the very moment when stronger action is needed, international funding is contracting. The decisions made now will shape the trajectory of AMR for decades. Reducing support is not just a financial recalibration; it is a choice that may have irreversible consequences for millions of people worldwide. The global community must act decisively to protect hard-won gains, support countries most at risk and uphold the shared responsibility of safeguarding the effectiveness of life-saving medicines. Dr Jose L Balcazar is a senior microbiologist at the Catalan Institute for Water Research (ICRA-CERCA), Spain.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store